Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment

NCT05642806 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps
Asthma
Chronic Rhinosinusitis Without Nasal Polyps

Interventions

BIOLOGICAL: Mepolizumab
OTHER: Placebo

Sponsor

St. Paul's Sinus Centre